FANCD2 and cystadenocarcinoma: Previously, we and others reported that Fancd2−/− mice develop multiple benign and malignant ovarian cancer phenotypes [17,32,33], including cystadenomas, cystadenocarcinomas, tubulostromal adenoma and adenocarcinomas, based on classifications defined by Mohr 2001 [38].